EUVIMEDEUVIMED entdecken
Open Access

Dysregulation of Serpinb6a-Gch1 axis contributes to DFNB91 deafness that is amendable to gene therapies

Cheng Cheng, Liyan Zhang, Jie Lu, Fangzhi Tan, Yideng Huang, Song Gao, Siyu Li, Yue Qiu, Wenli Hao, Yingyi Zhou, Junze Lu, Xinya Ji und 8 weitere

Molecular Therapy · 2026

DOI: 10.1016/j.ymthe.2026.01.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026. Verfasst von Cheng Cheng und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Jiangsu P…. Hauptthemen laut MEDLINE: Serpins, Genetic Therapy, Deafness. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Key Research and Development Program of China Stem Cell and Translational Research, Jiangsu Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary deafness accounts for 60% of congenital hearing loss, and more than 300 deafness genes have been identified. SERPINB6, a gene associated with recessive deafness, also named DFNB91, is linked to non-syndromic progressive hearing loss based on studies of humans and its mouse ortholog Serpinb6a knockout mice. However, the mechanism and biological therapy for SERPINB6 mutation-induced deafness remain unknown. Here, we demonstrate that Gch1 is aberrantly overexpressed in Serpinb6a-deficient hair cells. Upregulation of Gch1 in wild-type mice cochlea via adeno-associated virus (AAV) resulted in hearing loss and hair cell death, while downregulation of GCH1 by its inhibitor DAHP effectively protected hair cells and auditory function in Serpinb6a knockout mice. Dysregulation of the Serpinb6a/Gch1 axis resulted in elevated expression of BH4 and then iNOS, leading to increased ROS production and eventually causing hair cell damage. These findings revealed that Gch1 overexpression is the mechanism underlying deafness induced by Serpinb6a mutation. Critically, Myo15 promoter-driven AAV delivery of exogenous Serpinb6a effectively rescues auditory function and hair cell survival in Serpinb6a-deficient mice. These findings suggested that AAV-based gene therapy offers a potential treatment for Serpinb6a knockout mice, which may serve as a promising strategy for treating DFNB91 patients in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SerpinsGenetic TherapyDeafnessAnimalsMiceDependovirusMice, KnockoutHumansGenetic VectorsDisease Models, AnimalHair Cells, AuditoryMutationGene Expression Regulation

Stichwörter der Autor:innen

Gch1Serpinb6agene therapyhair celliNOS

Substanzen

Serpinsserpin B6

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Jiangsu Provincial Key Medical Discipline (Laboratory), No.321 Zhongshan Road,…
  • Department of Anatomy the Basic Medicine College, Inner Mongolia Medical University, Hohhot, Inner Mongolia 010000, China.
  • Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China.
  • Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, State Key Laboratory of Digital Medical Engineering, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Life Sciences and Technol…
  • Department of Otolaryngology, The First Affiliated Hospital of Wenzhou Medical University, Village ShangCai, Ouhai District, Wenzhou 325000, China.
  • Department of Radiology, Zhuhai People's Hospital, The Affiliated Hospital of Beijing Institute of Technology, Advanced Technology Research Institute, School of Life Science, Beijing Institute of Technology, Beijing 100…

Förderung

  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Jiangsu Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Cheng, C., Zhang, L., Lu, J., Tan, F., Huang, Y., Gao, S., Li, S., Qiu, Y., Hao, W., Zhou, Y., Lu, J., Ji, X., Li, A., Zhang, X., Fan, J., Li, H., Qian, X., Qi, J., Gao, X., & Chai, R. (2026). Dysregulation of Serpinb6a-Gch1 axis contributes to DFNB91 deafness that is amendable to gene therapies. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2026.01.030

Vancouver

Cheng C, Zhang L, Lu J, Tan F, Huang Y, Gao S, et al. Dysregulation of Serpinb6a-Gch1 axis contributes to DFNB91 deafness that is amendable to gene therapies. Molecular Therapy. 2026. doi:10.1016/j.ymthe.2026.01.030

BibTeX
@article{Cheng2026,
  author = {Cheng, Cheng and Zhang, Liyan and Lu, Jie and Tan, Fangzhi and Huang, Yideng and Gao, Song and Li, Siyu and Qiu, Yue and Hao, Wenli and Zhou, Yingyi and Lu, Junze and Ji, Xinya and Li, Ao and Zhang, Xinru and Fan, Jinyi and Li, He and Qian, Xiaoyun and Qi, Jieyu and Gao, Xia and Chai, Renjie},
  title = {Dysregulation of Serpinb6a-Gch1 axis contributes to DFNB91 deafness that is amendable to gene therapies},
  journal = {Molecular Therapy},
  year = {2026},
  doi = {10.1016/j.ymthe.2026.01.030}
}
Kostenlos starten →